Cardiovascular Therapeutics
The Division of Cardiovascular Therapeutics (CVT) is comprised of CII Investigators researching innovative therapies and technologies targeting the cardiovascular system. Division Investigators have internationally recognized expertise in all aspects of the life sciences, biomedicine, bioengineering, biotechnology and biomedical commercialization.
In addition to performing innovative basic and translational research, the Cardiovascular Therapeutics Division Investigators participate in setting national scientific and commercialization policy, facilitate the expansion of the local and national biotechnology communities and continue to train the next generation of scientists and clinical scientists through a number of competitive training programs.
A common focus of the Investigators is cell-based therapies: the use of cells as therapeutic agents for treating injury and illness. Researchers within the CVT addr
ess all aspects of developing and implementing cell-based therapies including determining what cells to use and how to collect them, discovering what the cells can do therapeutically and how to manipulate them to become therapeutic agents, and how to package the cells and deliver them back to the patient.
Activities within the Division include the exploration of the underlying biology of disease, the investigation of therapeutic cell behavior and utilization, the implementation of early and mid-phase biomedical commercialization processes, the performance of pre-clinical and clinical trials, as well as the development of new research methods, technologies and translation pathways.
Cell-based therapies and technologies are used not only clinical endeavors but also for improving commercialization practices via the development of experimental tissue mimics and other cell-based systems. While the therapies and technologies being developed within the Division are relevant to many diseases, much of CVT’s work emphasizes a variety of ischemic diseases and tissue repair situations involving the heart, peripheral tissues, and the central nervous system.
As research areas are continually expanded, the goal is to find cures that will assist in bettering patients’ lives.
Division Leader Principal InvestigatorsResearch Programs
- Therapeutic Cells
- Cellular Energetics
- Regenerative Cells
- Microvascular Reconstruction
More information concerning Cardiovascular Therapeutics.
